Cargando…

Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction

ABSTRACT: The RANK (receptor activator of nuclear factor κB)/RANKL (RANK ligand)/OPG (osteoprotegerin) axis is activated after myocardial infarction (MI), but its pathophysiological role is not well understood. Here, we investigated how global and cell compartment-selective inhibition of RANKL affec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slavic, Svetlana, Andrukhova, Olena, Ford, Kristopher, Handschuh, Stephan, Latic, Nejla, Reichart, Ursula, Sasgary, Soleman, Bergow, Claudia, Hofbauer, Lorenz C., Kostenuik, Paul J., Erben, Reinhold G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988763/ https://www.ncbi.nlm.nih.gov/pubmed/29736604 http://dx.doi.org/10.1007/s00109-018-1641-x

Ejemplares similares

Lack of vitamin D signalling per se does not aggravate cardiac functional impairment induced by myocardial infarction in mice
por: Ford, Kristopher, et al.
Publicado: (2018)

Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells
por: Streicher, Carmen, et al.
Publicado: (2017)

Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload
por: Slavic, Svetlana, et al.
Publicado: (2017)

Augmented Fibroblast Growth Factor-23 Secretion in Bone Locally Contributes to Impaired Bone Mineralization in Chronic Kidney Disease in Mice
por: Andrukhova, Olena, et al.
Publicado: (2018)

Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor‐23
por: Andrukhova, Olena, et al.
Publicado: (2015)

Vitamin D and Cardiovascular Disease, with Emphasis on Hypertension, Atherosclerosis, and Heart Failure
por: Latic, Nejla, et al.
Publicado: (2020)

FGF23 and Vitamin D Metabolism
por: Latic, Nejla, et al.
Publicado: (2021)

Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System
por: Latic, Nejla, et al.
Publicado: (2022)

FGF23 regulates renal sodium handling and blood pressure
por: Andrukhova, Olena, et al.
Publicado: (2014)

Activation of RAAS Signaling Contributes to Hypertension in Aged Hyp Mice
por: Latic, Nejla, et al.
Publicado: (2022)

Long-Term Excessive Dietary Phosphate Intake Increases Arterial Blood Pressure, Activates the Renin–Angiotensin–Aldosterone System, and Stimulates Sympathetic Tone in Mice
por: Latic, Nejla, et al.
Publicado: (2022)

Klotho Lacks a Vitamin D Independent Physiological Role in Glucose Homeostasis, Bone Turnover, and Steady-State PTH Secretion In Vivo
por: Anour, René, et al.
Publicado: (2012)

FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2–SGK1 signaling pathway
por: Andrukhova, Olena, et al.
Publicado: (2012)

Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice
por: Murali, Sathish K., et al.
Publicado: (2016)

Aldosterone Is Positively Associated With Circulating FGF23 Levels in Chronic Kidney Disease Across Four Species, and May Drive FGF23 Secretion Directly
por: Radloff, Judith, et al.
Publicado: (2021)

The bone is the major source of high circulating intact fibroblast growth factor-23 in acute murine polymicrobial sepsis induced by cecum ligation puncture
por: Bayer, Jessica, et al.
Publicado: (2021)

Processivity of C-Myc-Induced Telomerase Activation in Rat Cell Lines
por: Sasgary, Soleman, et al.
Publicado: (2001)

From bone to breast and back - the bone cytokine RANKL and breast cancer
por: Hofbauer, Lorenz C, et al.
Publicado: (2011)

Thioredoxin 1 is upregulated in the bone and bone marrow following experimental myocardial infarction: evidence for a remote organ response
por: Godoy, José R., et al.
Publicado: (2020)

Effects of Feed Contaminant Deoxynivalenol on Plasma Cytokines and mRNA Expression of Immune Genes in the Intestine of Broiler Chickens
por: Ghareeb, Khaled, et al.
Publicado: (2013)

Micro-osmotic pumps for continuous release of the tyrosine kinase inhibitor bosutinib in juvenile rats and its impact on bone growth
por: Tauer, Josephine Tabea, et al.
Publicado: (2013)

Prospects of adjuvant RANKL inhibition in breast cancer?
por: Rachner, T D, et al.
Publicado: (2015)

FGF23 promotes renal calcium reabsorption through the TRPV5 channel
por: Andrukhova, Olena, et al.
Publicado: (2014)

Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases
por: Morrissey, Colm, et al.
Publicado: (2007)

Impact of Long-Term Exposure to the Tyrosine Kinase Inhibitor Imatinib on the Skeleton of Growing Rats
por: Tauer, Josephine T., et al.
Publicado: (2015)

A phosphate and calcium-enriched diet promotes progression of 5/6-nephrectomy-induced chronic kidney disease in C57BL/6 mice
por: Radloff, J., et al.
Publicado: (2021)

Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
por: Quan, Gui-Hua, et al.
Publicado: (2015)

Inhibition of RANKL-Induced Osteoclastogenesis by Novel Mutant RANKL
por: Jang, Yuria, et al.
Publicado: (2021)

TNF-α and RANKL promote osteoclastogenesis by upregulating RANK via the NF-κB pathway
por: Luo, Gang, et al.
Publicado: (2018)

Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010)

From discovery of RANKL to clinical application of anti-human RANKL antibody
por: Yasuda, Hisataka, et al.
Publicado: (2012)

RANKL Expression in Periodontal Disease: Where Does RANKL Come from?
por: Chen, Bin, et al.
Publicado: (2014)

RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFα or anti-IL-1 therapies
por: Stolina, Marina, et al.
Publicado: (2009)

Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways
por: Zhou, Lin, et al.
Publicado: (2015)

Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway
por: Zhan, Jun-Kun, et al.
Publicado: (2014)

Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities
por: Joung, Youn Hee, et al.
Publicado: (2016)

Galangin suppresses RANKL‐induced osteoclastogenesis via inhibiting MAPK and NF‐κB signalling pathways
por: Li, Xiucheng, et al.
Publicado: (2021)

Carnosol inhibits osteoclastogenesis in vivo and in vitro by blocking the RANKL-induced NF-κB signaling pathway
por: Cai, Pan, et al.
Publicado: (2022)

Hematopoietic bone marrow cells participate in endothelial, but not epithelial or mesenchymal cell renewal in adult rats
por: Odörfer, Kathrin I, et al.
Publicado: (2011)

Targeting RANKL in metastasis
por: Dougall, William C, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_geer35l614kp0vqjgh39huhpbk